In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
MORE►
blind
Alvaro Guillem [Image: Courtesy Nanoscope Therapeutics]
Nanoscope Therapeutics Closes Series A, Names Alvaro Guillem as Chairman
by Lauren Hawkins | Jul 21, 2020
Nanoscope Therapeutics, a TechFW client, has closed an over-subscribed Series A funding round for its leading work on retinas, which could enable the blind to see.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
by David Kirkpatrick |
Jan 6, 2020
Envision Dallas will operate under parent company Envision, one of the largest employers of individuals with vision loss in the U.S.
MORE►
by Nicholas Sakelaris |
Jan 26, 2017
Dallasite Tish Cox is working with the nonprofit to employ blind and visually impaired workers to help produce her luxury clothing line.
MORE►
